Sign in
Back
A Phase 2 Randomized Trial To Evaluate Different Dose Regimens of Low-intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: Clinical Trial Update
Journal article   Peer reviewed

A Phase 2 Randomized Trial To Evaluate Different Dose Regimens of Low-intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: Clinical Trial Update

Jonathan E Katz, Manuel L Molina, Raul Clavijo, Nachiketh Soodana Prakash and Ranjith Ramasamy
European urology focus, Vol.4(3), pp.336-337
2018-04
DOI: https://doi.org/10.1016/j.euf.2018.07.011
PMID: 30025713

Abstract

Meta-Analysis as Topic Erectile Dysfunction - psychology Humans Middle Aged Clinical Protocols Male Treatment Outcome Erectile Dysfunction - epidemiology Extracorporeal Shockwave Therapy - methods Erectile Dysfunction - therapy Aged, 80 and over Adult Aged Testosterone - blood
Preliminary results from our study provide further evidence that low-intensity extracorporeal shockwave therapy is a safe and effective treatment modality for erectile dysfunction. Our treatment protocol with shockwaves given to men over 2 wk had the most robust effect.

Metrics

12 Record Views
15 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.142 Urology
1.142.484 Erectile Dysfunction
Web Of Science research areas
Urology & Nephrology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

Source: InCites

Details